Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Roivant Sciences Ltd (NASDAQ: ROIV) closed the day trading at $10.44 down -2.16% from the previous closing price of $10.67. In other words, the price has decreased by -$2.16 from its previous closing price. On the day, 5.69 million shares were traded. ROIV stock price reached its highest trading level at $10.7 during the session, while it also had its lowest trading level at $10.415.
Ratios:
For a better understanding of ROIV, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 37.91 and its Current Ratio is at 37.91. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 15, 2024, initiated with a Outperform rating and assigned the stock a target price of $17.
On January 05, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $20.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $14.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $14 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 24 ’25 when Venker Eric sold 434,478 shares for $10.82 per share. The transaction valued at 4,701,052 led to the insider holds 1,127,290 shares of the business.
Venker Eric sold 315,522 shares of ROIV for $3,489,673 on Mar 20 ’25. The President & COO now owns 959,457 shares after completing the transaction at $11.06 per share. On Mar 20 ’25, another insider, Venker Eric, who serves as the Officer of the company, bought 650,000 shares for $10.95 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ROIV now has a Market Capitalization of 7613568000 and an Enterprise Value of 2749760256. For the stock, the TTM Price-to-Sale (P/S) ratio is 76.36 while its Price-to-Book (P/B) ratio in mrq is 1.45. Its current Enterprise Value per Revenue stands at 22.431 whereas that against EBITDA is -2.293.
Stock Price History:
The Beta on a monthly basis for ROIV is 1.25, which has changed by -0.015682638 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, ROIV has reached a high of $13.06, while it has fallen to a 52-week low of $9.96. The 50-Day Moving Average of the stock is -3.10%, while the 200-Day Moving Average is calculated to be -7.76%.
Shares Statistics:
Over the past 3-months, ROIV traded about 5.13M shares per day on average, while over the past 10 days, ROIV traded about 8650830 shares per day. A total of 719.63M shares are outstanding, with a floating share count of 439.01M. Insiders hold about 38.48% of the company’s shares, while institutions hold 68.68% stake in the company. Shares short for ROIV as of 1741910400 were 52088746 with a Short Ratio of 10.16, compared to 1739491200 on 42397092. Therefore, it implies a Short% of Shares Outstanding of 52088746 and a Short% of Float of 9.790000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
